Swift Medical secures new financing round to further enhance its AI-based wound care technology

Ontario Industry UpdatesOBIO News
Written By Arsheen Kaur

Swift Medical, a digital health technology company serving wound care providers, recently announced the successful closing of an $US8M round of financing co-led by current investors BDC Capital’s Women in Technology Venture Fund and funds managed by Virgo Investment Group. Swift utilizes artificial intelligence to improve clinical and economic outcomes in chronic and acute wound care, and this financing will accelerate its pace of technology enhancements.

Swift Medical is an OBIO® member and an alumnus of our BDSP™ and CAAP® programs.

Arsheen Kaur
Previous

Virica expands bioprocessing capabilities with Carleton University partnership
Next

Eurofins CDMO Alphora announces the completion of a new pilot scale biologics development facility